ClinicalTrials.gov
ClinicalTrials.gov Menu

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00456794
Recruitment Status : Completed
First Posted : April 5, 2007
Last Update Posted : July 14, 2016
Sponsor:
Information provided by:
Kyowa Kirin Pharmaceutical Development, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2003
  Actual Study Completion Date : October 2003